|
|
| NurOwn derived Exosome based therapy / BrainStorm Cell Therap (0 Trials) |
|
| Nurr1 / Acadia Pharma (0 Trials) |
|
| Nurtec (riluzole sublingual) / Biohaven (0 Trials) |
|
| Nurtec ODT (rimegepant ODT) / Pfizer (0 Trials) |
|
| nurulimab (BCD-145) / Biocad (0 Trials) |
|
| NuSepin (taurodeoxycholic acid) / Shaperon (0 Trials) |
|
| NuThrax (AV7909) / Emergent Biosolutions (1 Trials) |
|
| Nutlin-3 / EMD Serono (0 Trials) |
|
| Nutropin AQ (somatropin) / Ipsen, Roche (6 Trials) |
|
| NUV-1182 / Nuvation Bio (0 Trials) |
|
| NUV-1511 / Nuvation Bio (0 Trials) |
|
| NUV-569 / Nuvation Bio (0 Trials) |
|
| NUV-868 / Nuvation Bio (0 Trials) |
|
| Nuvastatic (Orthosiphon stamineus/Orthosiphon aristatas botanical standardized extract) / NatureCeuticals (0 Trials) |
|
| Nuvion (visilizumab) / PDL (3 Trials) |
|
| nuvisertib (TP-3654) / Sumitomo Pharma (1 Trials) |
|
| Nuvocid (oritavancin) / Melinta Therap, Menarini (3 Trials) |
|
| Nuwiq (simoctocog alfa) / Octapharma (6 Trials) |
|
| Nuzyra (omadacycline) / Paratek (5 Trials) |
|
| NV 52 / Kazia (0 Trials) |
|
| NV-128 / MEI (0 Trials) |
|
| NV-CoV-1-R / NanoViricides (0 Trials) |
|
| NV-CoV-2 / NanoViricides (0 Trials) |
|
| NV-CoV-2-R / NanoViricides (0 Trials) |
|
| NV-HHV-101 / NanoViricides (0 Trials) |
|
| NV101 / NanoValent Pharma (0 Trials) |
|
| NV102 / NanoValent Pharma (0 Trials) |
|
| NV103 / NanoValent Pharma (0 Trials) |
|
| NVG-111 / Novalgen (0 Trials) |
|
| NVG-291 / NervGen (0 Trials) |
|
| NVL-330 / Nuvalent (0 Trials) |
|
| NVP-1805 / NVP Healthcare (0 Trials) |
|
| NVP-ADW742 / Novartis (0 Trials) |
|
| NVP-AEW541 / Novartis (0 Trials) |
|
| NVP-BVU972 / Novartis (0 Trials) |
|
| NVP-TAE226 / Novartis (0 Trials) |
|
| NVP014 / Abliva (0 Trials) |
|
| NVS32b1 / Novartis (0 Trials) |
|
| NVS32b2 / Novartis (0 Trials) |
|
| NVSI-06-09 / Sinopharm (0 Trials) |
|
| NVX-117 / Novelix (0 Trials) |
|
| NVX-207 / Novelix (0 Trials) |
|
| NVX-508 / NuvOx Pharma (0 Trials) |
|
| NVX-CoV2515 / Novavax (0 Trials) |
|
| NW-12-005 / Lupeng Pharma (0 Trials) |
|
| NW-2-146 / Lupeng Pharma (0 Trials) |
|
| NW-3-237 / Lupeng Pharma (0 Trials) |
|
| NW-4-241 / Lupeng Pharma (0 Trials) |
|
| NW-7-251 / Lupeng Pharma (0 Trials) |
|
| NW-8-153 / Lupeng Pharma (0 Trials) |
|
| NWL-149 / New World Labs (0 Trials) |
|
| NWL-154 / New World Labs (0 Trials) |
|
| NWL-283 / New World Labs (0 Trials) |
|
| NX-001 / NephRx (0 Trials) |
|
| NX-01 / Neoletix Biotech (0 Trials) |
|
| NX-019 / Nalo Therap (0 Trials) |
|
| NX-1607 / Nurix Therap (0 Trials) |
|
| NX-201 / NexGenix (0 Trials) |
|
| NX002 / NephRx (0 Trials) |
|
| NX04S1 / Nexien Biopharma (0 Trials) |
|
| NX04S2 / Nexien Biopharma (0 Trials) |
|
| NX1907 / Nextgen Biosci (0 Trials) |
|
| NX210 / Axoltis Pharma, Godfrin Life-Sci (0 Trials) |
|
| NX210c / Axoltis Pharma, Godfrin Life-Sci (0 Trials) |
|
| NXC-201 / Immix Biopharma (0 Trials) |
|
| NXC-301 / Immix Biopharma (0 Trials) |
|
| NXC-401 / Immix Biopharma (0 Trials) |
|
| NXC680 / Nextgen Biosci (0 Trials) |
|
| NXC736 / Nextgen Biosci (0 Trials) |
|
| NXE0039732 / Nxera Pharma (0 Trials) |
|
| NXL-002 / NeuExCell Therap (0 Trials) |
|
| NXL-003 / NeuExCell Therap (0 Trials) |
|
| NXN-188 / NeurAxon (0 Trials) |
|
| NXN-462 / NeurAxon (0 Trials) |
|
| NXP800 / Nuvectis Pharma (0 Trials) |
|
| NXP900 / Nuvectis Pharma (0 Trials) |
|
| NY-303 / NAYA Bio (0 Trials) |
|
| NY-338 / NAYA Bio (0 Trials) |
|
| NY-ESO-1 / Eutilex (0 Trials) |
|
| NY-ESO-1 combined with MPLA vaccine / National Institute of Science and Technology of Research in Immunology (0 Trials) |
|
| NY-ESO-1 Iscomatrix / Ludwig Institute for Cancer Research, CSL Behring (0 Trials) |
|
| NY-ESO-1 Peptide vaccine / Georgetown University (0 Trials) |
|
| NY-ESO-1 TCR / Gilead (2 Trials) |
|
| NY-ESO-1 TCR / Medigene (0 Trials) |
|
| NY-ESO-1 TCR / Treadwell Therap (0 Trials) |
|
| NY-ESO-1 TCR-T / Jibei Biotech, Genechem (0 Trials) |
|
| NY-ESO-1 TCR-T / UTC Therap (0 Trials) |
|
| NY-ESO-1 TCR-T cell therapy / Gilead (0 Trials) |
|
| NY-ESO-TCR / Agenus (0 Trials) |
|
| NYK-1001 / Nyken BV (0 Trials) |
|
| NYK1112 / Nyken BV (0 Trials) |
|
| Nylexa (cysteamine IV) / NovaBiotics (0 Trials) |
|
| Nymozarfex (fexapotide) / Nymox (1 Trials) |
|
| Nypozi (filgrastim-txid) / Tanvex BioPharma (0 Trials) |
|
| Nypta (tideglusib) / ASD Therap (0 Trials) |
|
| nystatin oral / Generic mfg. (5 Trials) |
|
| nystatin vaginal cream / Generic mfg. (1 Trials) |
|
| Nyvepria (pegfilgrastim-apgf) / Pfizer (1 Trials) |
|
| NYX-105 / Noxopharm (0 Trials) |
|
| NYX-2925 / Aptinyx (0 Trials) |
|
| NYX-458 / Aptinyx (0 Trials) |
|
| NYX-783 / Aptinyx (0 Trials) |
|
| Nyxol (phentolamine mesylate ophthalmic solution 1%) / Ocuphire Pharma (0 Trials) |
|
| NZ-687 / Nippon Zoki (0 Trials) |
|
| NZ-STING / Lidds (0 Trials) |
|
| NZV930 / Coherus Biosci (0 Trials) |
|
|